These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 22934786)

  • 1. Expansion of interferon-γ-secreting HIV-specific T cells during successful antiretroviral therapy.
    Gasser O; Brander C; Wolbers M; Brown NV; Rauch A; Günthard HF; Battegay M; Hess C;
    HIV Med; 2013 Apr; 14(4):241-6. PubMed ID: 22934786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional T cell subsets contribute differentially to HIV peptide-specific responses within infected individuals: correlation of these functional T cell subsets with markers of disease progression.
    Peretz Y; Ndongala ML; Boulet S; Boulassel MR; Rouleau D; Côté P; Longpré D; Routy JP; Falutz J; Tremblay C; Tsoukas CM; Sékaly RP; Bernard NF
    Clin Immunol; 2007 Jul; 124(1):57-68. PubMed ID: 17521962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional patterns of HIV-1-specific CD4 T-cell responses in children are influenced by the extent of virus suppression and exposure.
    Correa R; Harari A; Vallelian F; Resino S; Munoz-Fernandez MA; Pantaleo G
    AIDS; 2007 Jan; 21(1):23-30. PubMed ID: 17148964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral therapy-induced dominant interleukin-2 HIV-1 Gag CD4+ T cell response: evidence of functional recovery of HIV-1-specific CD4+ T cells.
    Tsalimalma K; Kordossis T; Choremi-Papadopoulou E
    Scand J Immunol; 2011 Mar; 73(3):256-65. PubMed ID: 21204901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-gamma and interleukin-10 responses.
    Ostrowski MA; Gu JX; Kovacs C; Freedman J; Luscher MA; MacDonald KS
    J Infect Dis; 2001 Nov; 184(10):1268-78. PubMed ID: 11679915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NYVAC immunization induces polyfunctional HIV-specific T-cell responses in chronically-infected, ART-treated HIV patients.
    Harari A; Rozot V; Cavassini M; Bellutti Enders F; Vigano S; Tapia G; Castro E; Burnet S; Lange J; Moog C; Garin D; Costagliola D; Autran B; Pantaleo G; Bart PA
    Eur J Immunol; 2012 Nov; 42(11):3038-48. PubMed ID: 22930439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of HIV-1 Gag-specific T cell responses in chronically infected Indian population.
    Kaushik S; Vajpayee M; Wig N; Seth P
    Clin Exp Immunol; 2005 Nov; 142(2):388-97. PubMed ID: 16232229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis.
    Tan DB; Yong YK; Tan HY; Kamarulzaman A; Tan LH; Lim A; James I; French M; Price P
    HIV Med; 2008 May; 9(5):307-16. PubMed ID: 18400078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar changes in plasmacytoid dendritic cell and CD4 T-cell counts during primary HIV-1 infection and treatment.
    Killian MS; Fujimura SH; Hecht FM; Levy JA
    AIDS; 2006 Jun; 20(9):1247-52. PubMed ID: 16816552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy.
    Keane NM; Price P; Lee S; Almeida CA; Stone SF; James I; French MA
    HIV Med; 2004 Nov; 5(6):407-14. PubMed ID: 15544692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low CD4 T-cell counts despite low levels of circulating HIV: insights from the comparison of HIV-1 infected patients with a discordant response to antiretroviral therapy to patients with untreated advanced HIV-2 disease.
    Albuquerque AS; Foxall RB; Cortesão CS; Soares RS; Doroana M; Ribeiro A; Lucas M; Antunes F; Victorino RM; Sousa AE
    Clin Immunol; 2007 Oct; 125(1):67-75. PubMed ID: 17692571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.
    French M; Keane N; McKinnon E; Phung S; Price P
    HIV Med; 2007 Apr; 8(3):148-55. PubMed ID: 17461858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication.
    Alatrakchi N; Duvivier C; Costagliola D; Samri A; Marcelin AG; Kamkamidze G; Astriti M; Agher R; Calvez V; Autran B; Katlama C
    AIDS; 2005 Jan; 19(1):25-33. PubMed ID: 15627030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy.
    Chang JJ; Wightman F; Bartholomeusz A; Ayres A; Kent SJ; Sasadeusz J; Lewin SR
    J Virol; 2005 Mar; 79(5):3038-51. PubMed ID: 15709024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with an HIV-1 immunogen induces CD4+ and CD8+ HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy.
    Valor L; Navarro J; Carbone J; Rodríguez-Sáinz C; Gil J; López F; Fernández-Cruz E;
    Vaccine; 2008 May; 26(22):2738-45. PubMed ID: 18433946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric HIV-1-specific cytotoxic T-lymphocyte responses suggesting ongoing viral replication despite combination antiretroviral therapy.
    Ching N; Yang OO; Deville JG; Nielsen-Saines K; Ank BJ; Sim MS; Bryson YJ
    Pediatr Res; 2007 Jun; 61(6):692-7. PubMed ID: 17426646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
    Goicoechea M; Smith DM; Liu L; May S; Tenorio AR; Ignacio CC; Landay A; Haubrich R
    J Infect Dis; 2006 Jul; 194(1):29-37. PubMed ID: 16741879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incomplete restoration of Mycobacterium tuberculosis-specific-CD4 T cell responses despite antiretroviral therapy.
    Hsu DC; Kerr SJ; Thongpaeng P; Iampornsin T; Pett SL; Zaunders JJ; Avihingsanon A; Ubolyam S; Ananworanich J; Kelleher AD; Cooper DA
    J Infect; 2014 Apr; 68(4):344-54. PubMed ID: 24325926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function.
    Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D;
    Antivir Ther; 2013; 18(1):125-30. PubMed ID: 22805174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between CD38 expression on peripheral blood T-cells and monocytes, and response to antiretroviral therapy: a one-year longitudinal study of a cohort of chronically infected ART-naive HIV-1+ patients.
    Almeida M; Cordero M; Almeida J; Orfao A
    Cytometry B Clin Cytom; 2007 Jan; 72(1):22-33. PubMed ID: 17051525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.